Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Folia Microbiol (Praha) ; 68(6): 823-833, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37118368

ABSTRACT

In the constant search for new pharmacological compounds, molecular hybridisation is a well-known technique whereby two or more known pharmacophoric subunits are combined to create a new "hybrid" compound. This hybrid is expected to maintain the characteristics of the original compounds whilst demonstrating improvements to their pharmacological action. Accordingly, we report here a series of molecular hybrid compounds based upon eugenol and chloramphenicol pharmacophores. The hybrid compounds were screened for their in vitro antimicrobial potential against Gram-negative and Gram-positive bacteria and also rapidly growing mycobacteria (RGM). The results highlight that the antimicrobial profiles of the hybrid compounds improve in a very clear fashion when moving through the series. The most prominent results were found when comparing the activity of the hybrid compounds against some of the multidrug-resistant clinical isolates of Pseudomonas aeruginosa, methicillin-resistant clinical isolates of Staphylococcus aureus (MRSA) and clinical isolates of rapidly growing mycobacteria.


Subject(s)
Anti-Infective Agents , Methicillin-Resistant Staphylococcus aureus , Chloramphenicol/pharmacology , Eugenol/pharmacology , Pharmacophore , Anti-Infective Agents/pharmacology , Staphylococcus aureus , Anti-Bacterial Agents/therapeutic use , Microbial Sensitivity Tests
2.
An Acad Bras Cienc ; 92(1): e20181021, 2020.
Article in English | MEDLINE | ID: mdl-32401841

ABSTRACT

Fosamprenavir calcium is an amprenavir prodrug of the protease inhibitors class used in the treatment of patients with acquired immunodeficiency syndrome (AIDS). Different solid forms of this drug are described in patents, in this sense studies on the physico-chemical characterization and stability are relevant for the selection of a solid form with adequate features for pharmaceutical purposes. In the present work form I (commercial) and amorphous of fosamprenavir calcium were characterized by the techniques of Differential Scanning Calorimetry (DSC), Thermogravimetry (TGA), Powder X-ray Diffraction (PXRD), Fourier-Transform Infrared Spectroscopy (FTIR) and Scanning Electron Microscopy (SEM). Furthermore, the chemical and polymorphic stability of the commercial form were evaluated by DSC, PXRD, FTIR and High-Performance Liquid Chromatography (HPLC). In the studies of characterization, thermal analyses allied to spectroscopic methods (PXRD and FTIR) demonstrated that the presence of water in the crystalline structure of Form I is fundamental for maintaining its crystallinity. In studies of accelerated stability the techniques of DSC, PXRD and FTIR showed that Form I does not suffer phase change when submitted to controlled conditions of temperature and humidity. Moreover, HPLC and FTIR proved the chemical stability of this solid form of fosamprenavir, thus demonstrating its suitability for pharmaceutical purposes.


Subject(s)
Carbamates/chemistry , Organophosphates/chemistry , Pharmaceutical Preparations/analysis , Sulfonamides/chemistry , Technology, Pharmaceutical/methods , Furans , Humidity , Microscopy, Electron, Scanning , Spectrum Analysis/methods , Temperature , Thermodynamics
SELECTION OF CITATIONS
SEARCH DETAIL
...